The intricate role of CCL5/CCR5 axis in Alzheimer disease
Weijiang Ma,Aihua Liu,Xinya Wu,Li Gao,Jingjing Chen,Hanxin Wu,Meixiao Liu,Yuxin Fan,Li Peng,Jiaru Yang,Jing Kong,Bingxue Li,Zhenhua Ji,Yan Dong,Suyi Luo,Jieqin Song,Fukai Bao
DOI: https://doi.org/10.1093/jnen/nlad071
2023-09-28
Journal of Neuropathology & Experimental Neurology
Abstract:Abstract The morbidity and mortality associated with Alzheimer disease (AD), one of the most common neurodegenerative diseases, are increasing each year. Although both amyloid β and tau proteins are known to be involved in AD pathology, their detailed functions in the pathogenesis of the disease are not fully understood. There is increasing evidence that neuroinflammation contributes to the development and progression of AD, with astrocytes, microglia, and the cytokines and chemokines they secrete acting coordinately in these processes. Signaling involving chemokine (C-C motif) ligand 5 (CCL5) and its main receptor C-C chemokine receptor 5 (CCR5) plays an important role in normal physiologic processes as well as pathologic conditions such as neurodegeneration. In recent years, many studies have shown that the CCL5/CCR5 axis plays a major effect in the pathogenesis of AD, but there are also a few studies that contradict this. In short, the role of CCL5/CCR5 axis in the pathogenesis of AD is still intricate. This review summarizes the structure, distribution, physiologic functions of the CCL5/CCR5 axis, and the progress in understanding its involvement in the pathogenesis of AD.
pathology,neurosciences,clinical neurology